Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
95.30    -1.10 (-1.14%)
Bid:
95.05
Ask:
95.15
Spread: 0.10 (0.105%)
Market Cap: £1.51b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Board Changes

28 May 2024 07:00

RNS Number : 9543P
Sirius Real Estate Limited
28 May 2024
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

28 May 2024

Sirius Real Estate Limited

("Sirius Real Estate" or the "Company")

Board Changes

Sirius Real Estate, the leading operator of branded business and industrial parks providing conventional space and flexible workspace in Germany and the UK, announces that James Peggie will step down as an independent non-executive director of the Company at the conclusion of the upcoming annual general meeting in June 2024 ("2024 AGM") and that Deborah Davis will join the Company's Board as an independent non-executive director, with effect from 1 December 2024.

 

Deborah Davis

 

Deborah spent her executive career in Sales, Marketing, Customer experience and Operations at some of the world's largest technology businesses including senior roles at PayPal, eBay, Symantec and Verizon Business. She holds an engineering honours degree in Applied Science (Electronics) from the University of Melbourne, a Masters degree in Science Management with Distinction from London Business School and is a Chartered Director (CDir).

 

Deborah is on the board of two listed companies, as Chair of diagnostic data and analytics company Diaceutics plc and Remuneration Committee Chair and Non-executive Director of consumer credit company International Personal Finance plc. She is also a Non-executive Director of Lloyds Banking Group Insurance/Scottish Widows Insurance Limited and was formerly a Non-executive Director of The Institute of Directors and of Norwegian listed biometrics company IDEX Biometrics ASA. She is also a trustee of the Southern African Conservation Trust.

 

James Peggie

 

James Peggie will step down from the Board and the Audit, Nomination and Remuneration Committees with effect from the conclusion of the 2024 AGM. James has been on the Board of Sirius since November 2012, and has been an outstanding steward of the Company, having overseen its transformation from an AIM-listed £60 million market capitalisation company to the £1.3 billion FTSE 250 and SAPY-indexed company it is today. During his tenure, James was Senior Independent Director for five years, chair of Sirius' Remuneration Committee for six years and also stood in twice as Board Interim Chair.

 

Commenting on the Board changes, Daniel Kitchen, Chair of Sirius Real Estate, said: "Deborah has impressive credentials as a respected board member across a range of listed, private and social enterprise organisations. She specifically brings a wealth of experience in growth, change and digital transformation in some of the largest technology companies in the world and will provide valuable insights as we continue to develop the use of technology in our business parks and our operating platform, as well as with helping us optimise our impact on society. We are confident that Deborah will be a valuable addition to our Board.

James has made an outstanding contribution to the Board during his tenure which started in 2012 when the company was a £60 million AIM-listed company. He has acted as Senior Independent Director, Interim Board Chair, chair of the Remuneration Committee and as a Member of the Audit and Nomination Committees. We thank him for his incredible support to the Company and the management team over the last 12 years."

The announcement has been made in accordance with requirements of the Listing Rule 9.6.11R of the Listing Rules published by the Financial Conduct Authority (the "Listing Rules") and paragraph 3.59 of the JSE Limited ("JSE") Listings Requirements.

For the purposes of LR 9.6.13R of the Listing Rules and paragraph 3.59 of the JSE Listings Requirements, Deborah Davis is currently a non-executive director of Diaceutics plc and International Personal Finance plc and was in the past five years a non-executive director of IDEX Biometrics ASA.

No further disclosures are required under LR 9.6.13R of the Listing Rules and paragraph 3.59 of the JSE Listings Requirements with respect to this appointment.

Deborah Davis and any 'persons closely associated' with her, have no beneficial interest in the Company's ordinary shares of no par value as at the date of this announcement. 

ENDS

For further information:

Sirius Real Estate

Andrew Coombs, CEO / Chris Bowman, CFO

+49 (0) 30 285010110

 

FTI Consulting (Financial PR)

Richard Sunderland / James McEwan / Talia Shirion / Millie James

+44 (0) 20 3727 1000

SiriusRealEstate@fticonsulting.com 

 

NOTES TO EDITORS

About Sirius Real Estate

Sirius is a property company listed on the main and premium market of the London Stock Exchange and the main board of the JSE. It is a leading owner and operator of branded business and industrial parks providing conventional space and flexible workspace in Germany and the U.K. As of 30 September 2023, the Group's portfolio comprised 139 assets let to 9,248 tenants with a total book value of over €2 billion, generating a total annualised rent roll of €184.2 million. Sirius also holds a 35% stake in Titanium, its €350+ million German-focused joint venture with clients of AXA IM Alts.

 

The Company's strategy centres on acquiring business parks at attractive yields and integrating them into its network of sites - both under the Sirius and BizSpace names and alongside a range of branded products. The business then seeks to reconfigure and upgrade existing and vacant space to appeal to the local market via intensive asset management and investment and may then choose to refinance or dispose of assets selectively once they meet maturity, to release capital for new investment. This active approach allows the Company to generate attractive returns for shareholders through growing rental income, improving cost recoveries and capital values, and enhancing returns through securing efficient financing terms.

 

For more information, please visit: www.sirius-real-estate.com

 

Follow us on LinkedIn at https://www.linkedin.com/company/siriusrealestate/

 

Follow us on X (Twitter) at @SiriusRE

 

 

 

JSE Sponsor

PSG Capital

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBVSRSAUVUAR
Date   Source Headline
30th Jul 20257:00 amRNSNotification of a transaction by a PDMR
25th Jul 202511:00 amRNSDealing in Securities
10th Jul 202511:00 amRNSDirector/PDMR Shareholding
9th Jul 20254:00 pmRNSDirector/PDMR Shareholding
8th Jul 202511:00 amRNSResult of AGM
2nd Jul 202511:00 amRNSNotice of change of AGM venue
30th Jun 20254:15 pmRNSTotal Voting Rights
26th Jun 20257:00 amRNSAcquisition in Geilenkirchen and Disposal of Asset
24th Jun 20257:00 amRNSSirius secures €150m Revolving Credit Facility
11th Jun 20253:00 pmRNSNotifications of transactions by PDMRs
9th Jun 20253:00 pmRNSNotification of a transaction by a PDMR and a PCA
6th Jun 20253:00 pmRNSNotification of a transaction by a PDMR
4th Jun 20254:15 pmRNSPosting of Annual Report and Notice of AGM
3rd Jun 20254:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNS-RSirius appoints Strategic Defence Adviser
2nd Jun 20252:47 pmRNSCash dividend and Dividend Reinvestment Plan
2nd Jun 20257:00 amRNSResults for the year ended 31 March 2025
30th May 20257:00 amRNSSirius agrees €43 million of German transactions
14th May 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSTrading Update
31st Mar 20254:15 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSSirius announces acquisition & disposal of assets
25th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 202512:00 pmRNSChanges to the board committees of the Company
12th Mar 20257:00 amRNSSirius agrees to acquire Southampton Business Park
11th Mar 20257:00 amRNSSirius sells Tyseley business park for £6.7m
17th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20252:00 pmRNSHolding(s) in Company
7th Feb 20253:00 pmRNSResults of Dividend Reinvestment Plan
6th Feb 20258:30 amRNS-RSenior hire strengthens Sirius leadership team
5th Feb 20251:00 pmRNS-RSirius acquires Earl Mill Business Park for £5.7m
4th Feb 20257:00 amRNSSirius to acquire Reinsberg business park
30th Jan 20257:00 amRNSRefinancing at Saarbrücken and MSCI AA ESG rating
29th Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSDirector/PDMR Shareholding
16th Jan 20257:00 amRNSCorporate Bond raising EUR 350 million
19th Dec 202411:00 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSAcquisition
2nd Dec 20242:00 pmRNSDirector update
27th Nov 202411:00 amRNSHolding(s) in Company
20th Nov 202411:30 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSDealing in Securities
18th Nov 20242:00 pmRNSDividend Declaration
18th Nov 20247:00 amRNSHalf-year Report
5th Nov 20247:00 amRNSSirius completes two acquisitions
4th Nov 20247:00 amRNSFitch reaffirms Sirius' BBB credit rating
7th Oct 20247:00 amRNSTrading Update
27th Sep 20243:00 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHolding(s) in Company
25th Sep 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.